Progesterone Receptor (PR), also known as NR3C3 (Nuclear Receptor Subfamily 3, Group C, Member 3), is an intracellular steroid receptor which mediates the physiological effects of progesterone, a female sex hormone involved in the menstrual cycle, pregnancy, and embryogenesis. Progesterone receptor expression has been linked to the prediction of prognosis in breast cancer, as well as associated responses to endocrine therapy. The progesterone receptor has also been linked to an increased risk for ovarian cancer.

• IHC751-Progesterone Receptor Datasheet-IVD

• MSDS
• 2021 NordiQC Assessment Report for IHC751: Optimal
• GeneAb™ IHC Antibodies ranked Optimal by NordiQC
• 2022 NordiQC Assessment Report for IHC751: Optimal

CLONE:
IHC751

ISOTYPE:
IgG1, kappa

HOST SPECIES:
Mouse

CLONALITY:
Monoclonal

POSITIVE CONTROL:
Breast, Breast Carcinoma

DILUTION RANGE:


INTENDED USE/REG. STATUS:
IVD

ADDITIONAL INFORMATION:
NordiQC Rating: Optimal
(Assessment Run 61 2021 and Run B33 2022)